Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (ARMP)

CUSIP: 04216R102

Q1 2022 13F Holders as of 31 Mar 2022

Holder snapshot 6 signals
Share change
+29,390
SEC-reported price per share
$4.89
Number of holders
15
Value change
+$136,417
Number of buys
7
Number of sells
5
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
67,070,688

Security key

04216R102

Report period

Q1 2022

Institutions

15

Top holders

10

Ownership snapshot

Top reported holders of ARMP - Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BANK OF AMERICA CORP /DE/
Disclosed value leader
BANK OF AMERICA CORP /DE/
Comparable rows
0/15
Latest evidence
31 Dec 2021
13F Highest disclosed value: $3,474,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

BANK OF AMERICA CORP /DE/ has the largest disclosed position value at $3.47M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BANK OF AMERICA CORP /DE/'s linked filing trail.
Disclosed position value Top 5
BANK OF AMERICA CORP /DE/ $3.47M
VANGUARD GROUP INC $1.44M
BRIDGEWAY CAPITAL MANAGEMENT, LLC $623K
EDGEWOOD MANAGEMENT LLC $548K
RENAISSANCE TECHNOLOGIES LLC $465K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BANK OF AMERICA CORP /DE/
13F
Company
13F
—
denominator unverified
$3,474,000
633,944 shares
— 31 Dec 2021
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$1,440,000
262,750 shares
— 31 Dec 2021
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$623,000
113,682 shares
— 31 Dec 2021
EDGEWOOD MANAGEMENT LLC
13F
Company
13F
—
denominator unverified
$548,000
100,000 shares
— 31 Dec 2021
RENAISSANCE TECHNOLOGIES LLC
13F
Company
13F
—
denominator unverified
$465,000
84,796 shares
— 31 Dec 2021
SYNOVUS FINANCIAL CORP
13F
Company
13F
—
denominator unverified
$263,000
48,035 shares
— 31 Dec 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
15
Shares
1,351,550
Rows available
15
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2022 vs Q2 2026 Across Filers

Q2 2026 holders
53
Q1 2022 holders
15
Holder diff
-38
Investor Q2 2026 Shares Q1 2022 Shares Share Diff Share Chg % Q2 2026 value Q1 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .